Dose Ranging Study With LT, Monotherapy, PPAR

Inclusion Criteria: * 1\. HbA1c \> 7.0% and ≤ 10.0% obtained at the Screening visit. * 2\. Men and women, 18-70 years of age Established Type 2 diabetes Exclusion Criteria: * 1\. Symptomatic Type 2 diabetes defined as marked polyuria and polydipsia with greater than 10% weight loss during the last three months. * 2\. Administration of antihyperglycemic agents (other than thiazolidinediones) for more than three consecutive or a total of seven non-consecutive days during the four weeks prior to screening. * 3\. Administration of thiazolidinediones for more than three consecutive or a total of seven non-consecutive days during the six weeks prior to screening.